Silicone breast implants: The role of immune system on capsular contracture formation

1995 ◽  
Vol 29 (2) ◽  
pp. 197-202 ◽  
Author(s):  
Donatella Granchi ◽  
Daniela Cavedagna ◽  
Gabriela Ciapetti ◽  
Susanna Stea ◽  
Patrizia Schiavon ◽  
...  
2016 ◽  
Vol 69 (1) ◽  
pp. 70-76 ◽  
Author(s):  
Katherine E. Miller ◽  
Bernardo Hontanilla ◽  
Alvaro Cabello ◽  
Diego Marre ◽  
Leticia Armendariz ◽  
...  

2019 ◽  
Vol 70 (5) ◽  
pp. 1619-1624
Author(s):  
Silviu Adrian Marinescu ◽  
Dan Mircea Enescu ◽  
Catalin Gheorghe Bejinariu ◽  
Carmen Giuglea

The upward trend of patients opting for elective breast augmentation, as well as the large number of patients benefiting from alloplastic breast reconstruction, require further studies on the safety profile of these techniques. Without any doubt, the incidence of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has drawn attention to the possible unknown complications characteristic of these procedures, creating the context of further studies devoted to this issue. The present research examines the capsular contracture rate on a group of 253 patients between 2015 and 2019, also proposing a scoring system based on the integration of the main diagnostic criteria related to the capsular contracture. The results of the literature review indicate that a lower incidence of capsular contracture could be achieved by using the newest techniques in the field involving the application of chemical substances on the surface of the latest generation of silicone breast implants.


Biomolecules ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. 1436
Author(s):  
Vânia Borba ◽  
Anna Malkova ◽  
Natalia Basantsova ◽  
Gilad Halpert ◽  
Laura Andreoli ◽  
...  

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) was first introduced in 2011 by Shoenfeld et al. and encompasses a cluster of related immune mediated diseases, which develop among genetically prone individuals as a result of adjuvant agent exposure. Since the recognition of ASIA syndrome, more than 4400 documented cases have been reported so far, illustrated by heterogeneous clinical manifestations and severity. In this review, five enigmatic conditions, including sarcoidosis, Sjögren’s syndrome, undifferentiated connective tissue disease, silicone implant incompatibility syndrome (SIIS), and immune-related adverse events (irAEs), are defined as classical examples of ASIA. Certainly, these disorders have been described after an adjuvant stimulus (silicone implantation, drugs, infections, metals, vaccines, etc.) among genetically predisposed individuals (mainly the HLA-DRB1 and PTPN22 gene), which induce an hyperstimulation of the immune system resulting in the production of autoantibodies, eventually leading to the development of autoimmune diseases. Circulating autonomic autoantibodies in the sera of patients with silicone breast implants, as well as anatomopathological aspects of small fiber neuropathy in their skin biopsies have been recently described. To our knowledge, these novel insights serve as a common explanation to the non-specific clinical manifestations reported in patients with ASIA, leading to the redefinition of the ASIA syndrome diagnostic criteria.


2016 ◽  
Vol 88 (3) ◽  
pp. 1459-1470 ◽  
Author(s):  
VILBERTO J. VIEIRA ◽  
ARMANDO D'ACAMPORA ◽  
FERNANDA S. NEVES ◽  
PAULO R. MENDES ◽  
ZULMAR A. DE VASCONCELLOS ◽  
...  

Author(s):  
Massimiliano Fraldi ◽  
Luca Esposito ◽  
Arsenio Cutolo ◽  
Angelo Rosario Carotenuto ◽  
Ciro Adamo ◽  
...  

2018 ◽  
Vol 41 (5) ◽  
pp. 563-570 ◽  
Author(s):  
Y. Bachour ◽  
Z. C. M. Heinze ◽  
T. S. Dormaar ◽  
W. G. van Selms ◽  
M. J. P. F. Ritt ◽  
...  

2019 ◽  
Vol 1 (3) ◽  
Author(s):  
Maurizio Saturno ◽  
Sharon Stewart ◽  
Erin Bell ◽  
Emanuela Esposito

Abstract Background Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture, and rupture are risks often associated with breast implants. Objectives The authors conducted a retrospective study to analyze and report complication rates associated with Eurosilicone’s (Eurosilicone S.A.S, Apt, Cedex, France) silicone gel–filled breast implants over a period of 5 years. Methods In this retrospective clinical study, 2151 women who underwent either breast augmentation or breast reconstruction with Eurosilicone breast implants were diagnosed. Data on early and late complications including implant removal (explantation/exchange), capsular contracture, and rupture were collected using questionnaires, completed by 39 surgeons across Italy. Results Of the 2151, only 60 patients (2.78%) required implant removal. Twenty-five patients experienced capsular contracture (Baker Grade III/IV), giving an actual rate of 1.2%. The actual rate of implant rupture confirmed by breast magnetic resonance images was 0.18% (4 implants). Six patients (0.27%) were diagnosed with breast cancer following breast augmentation, and local complications including hematoma (1 patient) and seroma (2 patients) were experienced. Conclusions This retrospective clinical study involving Eurosilicone’s round and anatomical textured silicone gel–filled mammary implants demonstrates an excellent safety profile through 5 years. Level of Evidence: 2


Sign in / Sign up

Export Citation Format

Share Document